List of products in the National Drug Code with proprietary name . Ocrelizumab is used to treat certain forms of multiple sclerosis-MS (relapsing or primary progressive forms). It is not a cure for MS, but it is thought to help slow down nerve damage, reduce the number of relapses, and delay disability. Ocrelizumab belongs to a class of drugs known as monoclonal antibodies.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
50242-151 OcrelizumabInjectionGenentech, Inc.Drug For Further Processing